This webinar walks through key considerations and helpful guidelines to accelerate next-generation sequencing (NGS)-based clinical genomics assay validation for less money and greater confidence in results.
NGS has revolutionized how assay developers, laboratories, and clinicians are diagnosing, treating, and managing disease. But before a clinical genomics assay can help guide patient care, it must be thoroughly validated. While validation principles are universal, the complexities of NGS can make the process a daunting task. In this webinar, clinical genomics expert Dr. Bob Daber uses real-world examples to highlight how highly multiplexed, patient-like biosynthetic reference materials offer substantial time and cost advantages over traditional materials and methods.
View this webinar to learn:
- Specific ways you can save time and money while thoroughly validating an NGS-based clinical genomics assay
- Validation best practices from leading clinical genomics laboratories
- How to navigate the many guidelines and requirements of the various authoritative bodies for clinical genomics testing